Cargando…
HLA-G: A New Immune Checkpoint in Cancer?
Human leukocyte antigen G (HLA-G), known as a central protein in providing immune tolerance to the fetus in pregnant women, is also studied for a possible role in tumor development. Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might be targ...
Autores principales: | Krijgsman, Daniëlle, Roelands, Jessica, Hendrickx, Wouter, Bedognetti, Davide, Kuppen, Peter J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350262/ https://www.ncbi.nlm.nih.gov/pubmed/32630545 http://dx.doi.org/10.3390/ijms21124528 |
Ejemplares similares
-
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy
por: Bedognetti, Davide, et al.
Publicado: (2017) -
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
por: Roelands, Jessica, et al.
Publicado: (2017) -
Human Leukocyte antigen-G (HLA-G) and gastrointestinal malignancy
por: Nazemalhosseini-Mojarad, Ehsan, et al.
Publicado: (2014) -
A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
por: van de Water, Ricky B., et al.
Publicado: (2021) -
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
por: Attia, Jiji V. D., et al.
Publicado: (2020)